30 October 2018 - The Trump administration is writing Act Two of its effort to address the country’s high prescription drug costs — and this next move could apply to a much broader swath of the Medicare program.

A proposal having to do with Medicare Part D — which foots the vast majority of seniors’ drug bills — was posted yesterday to the White House’s Office of Management and Budget website, generating much buzz in the industry about what the administration might be planning next.

It’s unlikely any new rule on drug prices will be released before next week’s midterm elections, perhaps over fears it could fuel Democratic charges that Republicans are trying to cut seniors’ drug benefits at a time when health care is playing a central role in the heated campaign. But the notice of the proposal signals the administration has more coming down the pike as it tries to look tough on the drug industry.

Read Washington Post article